In this expert’s corner video, David Harlan, MD, explains cutting-edge research at UMass Medical School that allows scientists to better understand how the immune system attacks insulin-producing cells in the pancreas, leading to diabetes.
With an $11 million, 5-year program project grant from the National Institute of Allergy and Infectious Diseases, Christopher M. Sassetti, PhD, and an international team of researchers will study the underlying biology of tuberculosis.
A new study co-authored by Guillaume Poirier, PhD, of the Center for Comparative Neuroimaging finds that menthol administered with nicotine alters connectivity patterns in an area of the brain associated with drug reward and addiction and results in behavioral changes.
Family medicine & community health faculty Ronald Adler, MD, and Frank Domino, MD, will continue counseling patients about lifestyle modifications as well as medication to manage blood pressure and reduce cardiovascular disease risk rather than striving to achieve a set point for all, despite stringent new guidelines from the American College of Cardiology and the American Heart Association.
Dean Terence R. Flotte served as senior author on a call to action published in Academic Medicine, titled, “It is time for zero tolerance for sexual harassment in academic medicine.”
UMass Medical School is providing flu shots to faculty, staff and students, free of charge, at on-campus clinics throughout November.
The 19th annual UMass Medicine Cancer Walk & Run surpassed its fundraising goal, bringing in $560,000 to support cancer research and treatment at UMass Medical School and UMass Memorial Medical Center.
The new federal commission on the opioid crisis will urge the Department of Justice to establish federal drug courts nationwide to better connect addicts with lifesaving treatment, a judicial system Massachusetts has used for years and recently improved with the help of UMass Medical School. Ira Packer, PhD, serves as director of the Center of Excellence for Specialty Courts.
UMass Medical School’s 2017 COMECC campaign is now underway and continues through Nov. 22.
Abraham L. Brass, MD, PhD, received a grant from Gilead Sciences to undertake translational research investigating the interaction between HIV and host cells.